Franck Morschhauser
Lille haematologist and President of LYSA, the French-Belgian lymphoma cooperative group, who led the RELEVANCE trial of chemotherapy-free therapy in follicular lymphoma.
Overview
Franck Morschhauser is President of LYSA, the Lymphoma Study Association, and Professor of Haematology at Lille University Hospital, France. He was first author of the RELEVANCE trial comparing rituximab plus lenalidomide with rituximab-chemotherapy in untreated follicular lymphoma. His research spans novel immunotherapies and targeted agents across indolent and aggressive B-cell lymphomas.
| Title | Journal | Year |
|---|---|---|
| Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma | New England Journal of Medicine | 2018 |
Pages like this
not linked directly; found by shared links- PersonYuqin Song
Shares Follicular lymphoma, Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
- PersonSascha Dietrich
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma, haematology.
- PersonLim Soon Thye
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
- PersonSteven Le Gouill
Shares LYSA – The Lymphoma Study Association, Diffuse large B-cell lymphoma.
- PersonFranco Cavalli
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
- PersonSirpa Leppä
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
- PersonJackson Orem
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
- PersonArmando Santoro
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.